The absence of HLA-DR is an important marker of human MDSCs and in one study it has been shown that IL-6 blockers can partially elevate HLA-DR expression, considering the decreased MDSC levels in patients with severe COVID-19 (46). This evidence concerns the gene IL6 and COVID-19.